Valuation : 10x Genomics, Inc.

Market Cap 8.16B 7.02B 6.61B 6.04B 11.29B 771B 11.32B 78.09B 30.3B 395B 30.65B 29.98B 1,274B P/E 2026 *
-85.9x
P/E 2027 * -89.3x
Enterprise Value 7.68B 6.61B 6.22B 5.68B 10.62B 725B 10.65B 73.46B 28.51B 372B 28.83B 28.21B 1,198B EV / Sales 2026 *
12.4x
EV / Sales 2027 * 11.2x
Free-Float
90.86%
Yield 2026 *
-
Yield 2027 * -
1 day-0.90%
1 week+1.80%
Current month+0.32%
1 month+32.01%
3 months+101.84%
6 months+189.51%
Current year+284.12%
1 week 58.7
Extreme 58.7
63.89
1 month 44.39
Extreme 44.39
66.94
Current year 15.9
Extreme 15.9
66.94
1 year 11.16
Extreme 11.16
66.94
3 years 6.78
Extreme 6.78
66.94
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 02/07/2012
President 51 01/10/2012
Director of Finance/CFO 51 12/08/2024
Director TitleAgeSince
Director/Board Member 51 02/07/2012
Director/Board Member 49 02/07/2012
Chairman 68 01/08/2013
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Don

Founder

-100 0.0001%
26/08/26 Sell

Founder

-10,486 0.0090%
24/08/26 Sell

Chief Financial Officer

-17,166 0.0147%
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%+1.80%+348.78%+19.38% 8.16B
+0.23%-0.06%+168.44%+357.12% 21.66B
-2.24%-1.33%-37.24%-20.96% 10.16B
-0.99%-2.18%-28.06% - 7.08B
-0.01%+0.20%+84.42%+52.87% 6.59B
+2.34%-1.27%-20.74%-15.41% 6.03B
-1.82%-1.64%-8.48%-20.67% 4.33B
-0.62%-0.38%+74.99%+85.77% 4.22B
+1.82%-0.27%-18.67%-28.71% 2.81B
+2.23%+6.01% - - 1.39B
Average +0.00%+0.22%+62.60%+53.67% 7.24B
Weighted average by Cap. -0.28%-0.14%+92.58%+127.08%

Financials

2026 *2027 *
Net sales 620M 534M 502M 459M 858M 58.57B 861M 5.94B 2.3B 30.05B 2.33B 2.28B 96.82B 680M 585M 551M 503M 941M 64.2B 943M 6.51B 2.52B 32.94B 2.55B 2.5B 106B
Net income -95.77M -82.41M -77.54M -70.83M -133M -9.04B -133M -916M -356M -4.64B -360M -352M -14.95B -89.66M -77.15M -72.59M -66.31M -124M -8.47B -124M -858M -333M -4.34B -337M -329M -13.99B
Net Debt -484M -416M -392M -358M -670M -45.69B -671M -4.63B -1.8B -23.44B -1.82B -1.78B -75.52B -539M -464M -437M -399M -746M -50.91B -748M -5.16B -2B -26.12B -2.02B -1.98B -84.16B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
04/09/26 $62.65 -0.90% 1,469,824
03/09/26 $63.22 +2.55% 2,172,711
02/09/26 $61.65 +2.78% 1,604,988
01/09/26 $59.98 -3.96% 1,963,698
31/08/26 $62.45 +1.48% 2,656,719
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
62.65USD
Average target price
51.00USD
Spread / Average Target
-18.60%

Quarterly revenue - Rate of surprise